Sao Paulo, Brazil
In July, ISPE Brazil Affiliate held its’ 8th annual Brazilian Cold Chain Day, immersing attendees in the study of good pharmaceutical practices related to temperature control logistics. More than 50 professionals from different areas and companies in Brazil and abroad learned and shared knowledge, experience, and best practices in the market, while enjoying an outstanding networking opportunity.
The cold chain market in Brazil controls more than $3 billion USD/year in imports and exports. In addition to a growing challenge in compliance requirements throughout Latin America, the need for continuous training and enhancement of the various individuals that contribute to this vital aspect of the Pharmaceutical Supply Chain ensure the success of this event, year after year.
Cold Chain Day instructors, each of which is a member of the ISPE Brazil Affiliate, included:
By: Totsopan Santitewagun, ISPE Thailand President
The ISPE Thailand Affiliate celebrated its 15th anniversary at its’ 2018 Annual Meeting on July 16-18. More than 350 participants at the event were comprised of regulators from our neighbor countries, Singapore, Malaysia, Indonesia, and Philippines Affiliate Board Members, and delegates from Thailand and overseas. This was the first ISPE meeting with the Association of Southeast Asian Nations (ASEAN) in which regulators from Myanmar and Laos, both of which are in CLVM (Cambodia, Laos, Vietnam, and Myanmar) countries, participated in the event. The regulatory sessions were led by Bob Tribe, the ISPE Regulatory Affairs Adviser.
ISPE Affiliates and Chapters offer the opportunity to network with industry professionals in your region and local language. From training events and conferences to mentoring opportunities and social gatherings, ISPE's Affiliates and Chapters keep you connected to the industry at the local level.
In the pharmaceutical industry, which is highly regulated, aseptic processing is a critical component that ensures the sterility of products. Regulators have a set of comprehensive requirements that minimize the risk of contamination. Regulators set the requirements; however, the industry has an obligation to the patients who rely on and expect a drug that is safe and free of contamination....
Like any investment in digital manufacturing systems, demonstrating business payback before and after investment is critical to getting MES projects approved and verifying profitability after investment. Whether it is introducing MES, expanding it to additional sites, switching software, upgrading existing software, or developing electronic production records (EPR) for new drug products,...
Sustainability is emerging as a pivotal force influencing the pharmaceutical industry’s dynamics and steering companies towards transformative change. The focus of this analysis is to delve into the sustainability key performance indicators (KPIs) of prominent pharmaceutical players, namely Pfizer, Sanofi, Glaxo Smith Kline (GSK), Becton Dickinson, Johnson & Johnson, Abbott, Eli Lilly, and...